JNJ

Can J&J's Pharma Segment Deliver Meaningful Growth?
Motley Fool
Tue, 04/8/14 - 09:43 am
JNJ
5 Biotechs With Prostate Cancer Treatments Worth Watching
Motley Fool
Sun, 04/6/14 - 10:21 am
JNJ
Zytiga
Xofigo
Bayer
Dendreon
Provenge
prostate cancer
Seattle Genetics
Progenics
[video]Drugmakers Build to Buy
Motley Fool
Fri, 04/4/14 - 09:25 am
Biogen Idec
Atlas Venture
Celgene
Versant Ventures
GSK
Avalon Ventures
JNJ
J&J Must Pay Damages Mesh Incontinence Implant Verdict
Bloomberg
Fri, 04/4/14 - 09:16 am
JNJ
transvaginal mesh
Ethicon
$4B deal: J&J sells lab testing unit to Carlyle
USA Today
Mon, 03/31/14 - 09:36 am
JNJ
M&A
Carlyle
diagnostics
Ortho-Clinical Diagnostics
Women suing J&J over pelvic implant injuries allege it destroyed documents, seek US probe
Yahoo/AP
Thu, 03/27/14 - 08:16 am
transvaginal mesh
JNJ
Depomed A 'Turtle' Gaining In Specialty Pharma Race
Investors.com
Wed, 03/26/14 - 11:39 am
Depomed
Cambia
Gralise
Xartemis XR
JNJ
Mallinckrodt
Nucynta
J&J releases more Doxil, its popular cancer med that has been dogged by supply issues
Fierce Pharma
Mon, 03/24/14 - 06:24 pm
drug shortages
JNJ
Doxil
Big pharma balks at investment in TB
Financial Times
Mon, 03/24/14 - 08:33 am
tuberculosis
R&D
AstraZeneca
JNJ
Experimental J&J psoriasis drug shows promise in study
Yahoo/Reuters
Sat, 03/22/14 - 12:10 pm
JNJ
psoriasis
guselkumab
J&J-Medivir Hepatitis C Drug Recommended by EU Regulator
Bloomberg
Fri, 03/21/14 - 10:21 am
JNJ
hepatitis C
Europe
Medivir
Olysio
J&J blazes a new pharma trail with industry's first designer-in-chief
Fierce Pharma
Thu, 03/20/14 - 05:53 pm
JNJ
product design
J&J gets $1.2 billion Arkansas Risperdal judgment tossed out
Yahoo/Reuters
Thu, 03/20/14 - 05:21 pm
JNJ
Risperdal
Arkansas
Don't bet on a home-run drug launch, even for power-hitting drugs
Fierce Pharma
Wed, 03/19/14 - 03:50 pm
drug launches
JNJ
Zytiga
Johnson & Johnson's Sale Of K-Y Brand To Reckitt Benckiser Confirms Focus on Pharma
Forbes
Wed, 03/19/14 - 09:51 am
JNJ
Reckitt Benckiser
K-Y
The best-selling cancer drugs in 2013 and 2018: Roche dominates while immunotherapies, Johnson & Johnson emerge as contenders
First Word Pharma
Mon, 03/17/14 - 10:06 am
Roche
cancer
JNJ
J&J Lawsuit Sheds Light on Link Between Doctors and Device Makers
Wall St Cheat Sheet
Sat, 03/15/14 - 10:11 am
JNJ
lawsuits
devices
Medical device maker Hologic names ex-J&J exec to new COO post
Yahoo/Reuters
Fri, 03/14/14 - 10:13 am
devices
JNJ
Hologic
Eric Compton
Johnson & Johnson's Success In Cardiac Ablation
Seeking Alpha
Thu, 03/13/14 - 05:47 pm
cardiac ablation
JNJ
devices
Biosense Webster
St. Jude Medical
SmartTouch catheter
J&J partners with a biotech start-up on a new approach to Alzheimer's
Fierce Biotech
Mon, 03/10/14 - 10:19 am
JNJ
Alzheimer's disease
Alector

Pages